Startup of the day: S.Lab Ukrainian eco-friendly packaging made from waste and mycelium

Startup of the day: S.Lab Ukrainian eco-friendly packaging made from waste and mycelium S.Lab is a Ukrainian startup that creates eco-friendly packaging from waste and mycelium. The company helps businesses minimize their environmental impact and contribute to the development of a sustainable future. The Startup of the Day column on

Record profits. Samsung forecasts a threefold increase in operating profit thanks to the AI boom

Record profits. Samsung forecasts a threefold increase in operating profit thanks to the AI boom Samsung Electronics predicts that the company’s operating profit in the fourth quarter will triple and reach a record high due to chip shortages and demand for artificial intelligence, Reuters reports. The company’s profit for October-December

Discord and Mercor investor to launch own fund. Nico Bonatsos leaves General Catalyst

Discord and Mercor investor to launch own fund. Nico Bonatsos leaves General Catalyst Investor Niko Bonatsos, who has long led the seed strategy at venture capital firm General Catalyst, has announced his departure from the firm. He plans to launch his own venture fund for early-stage investments. Bonatsos is known

United States–Ukraine Reconstruction Investment Fund has begun accepting applications. Who is eligible to apply?

United States–Ukraine Reconstruction Investment Fund has begun accepting applications. Who is eligible to apply? The Ministry of Economy of Ukraine and the US International Development Finance Corporation (DFC) have begun accepting investment projects for United States–Ukraine Reconstruction Investment Fund. This was reported by the Ministry of Economy. According to Economy

CertHub raises €6.2M to tackle medtech’s compliance bottleneck

CertHub raises €6.2M to tackle medtech’s compliance bottleneck CertHub raises €6.2M to transform MedTech compliance with AI-driven automation Munich-based medtech manufacturing compliance startup  CertHub,has raised €6.2 million in investment in just two months. Across Europe, medtech companies are facing unprecedented regulatory pressure. 70 per cent of manufacturers report significant struggles